|
Australia-QLD-NORWELL Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- Absence of airflow obstruction on spirometry: can it still be . . .
Occasionally, however, FVC decreases roughly in tandem with FEV 1 as RV increases despite a preserved TLC, reflecting increased small airway collapse closure at low lung volumes during the forced maneuver 5 In fact, a sizeable number of symptomatic smokers with no spirometric evidence of obstruction may show gas trapping and or ↓DLCO plus
- Chronic Respiratory Symptoms with Normal Spirometry. A . . .
We review the association between chronic respiratory symptoms, excess decline of FEV 1, and development of COPD and the evidence for a potential new clinical entity in individuals with chronic respiratory symptoms and normal spirometry (post-bronchodilator FEV 1 FVC ≥ 0 7)
- Should We Consider Screening Spirometry in Individuals Who . . .
Thirty percent of those with no AFO and prior diagnosis of COPD were asymptomatic Despite the absence of respiratory symptoms, those individuals had a higher risk for exacerbations, pneumonia, and all-cause mortality than those with no COPD
- Office Spirometry for Lung Health Assessment in Adults
Office spirometry is considered to be a part of a clinical evaluation and does not fall under the definition of a screening test when performed for patients with respiratory symptoms who are seen during a clinical encounter (whether or not they have a history of cigarette smoking)
- Respiratory symptoms and small airway dysfunction in current . . .
Chronic respiratory symptoms are commonly reported by current and former cigarette smokers who lack spirometric evidence of COPD These individuals are more likely to experience wheezing, breathlessness, limitation in exercise, chronic bronchitis, worse quality of life, exacerbations and more co-morbidities than healthy never-smokers 1 - 4 (Fig
- Decreased quality of life and spirometric alterations even . . .
The follow-up of recovered COVID-19 patients is still limited We aimed to evaluate the changes in quality-of-life (QOL) and spirometric alterations in the convalescent phase of 115 patients with at least 30 days post-COVID-19
|
|